Joint Formulary & PAD

Formulary Search

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Search

A-Z of Drugs : A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

A-Z of Drugs

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Search Results : Sleep disorders in Children and Young People with neurodevelopmental disorders (Melatonin - Sleep disorders in Children and Young People with ADHD)

Show Icon and Status Keys

Drug
Indication
Status
Restrictions/Comments
Formulary Status
Links
Status :
Blue
Formulations :
  • Modified release tablets
Restrictions / Comments:

Important
Preferred

Initiation and stabilisation for at least 1 month by the mental health specialist team before any request to transfer prescribing to Primary Care.

More detail and resources are provided on the PAD page (accessed by clicking the drug name).

2mg modified release tablets.

 
Links :
Off Label
SPC
Status :
Blue
Formulations :
  • Immediate release tablets
Restrictions / Comments:

Important

Initiation and stabilisation for at least 1 month by the mental health specialist team before any request to transfer prescribing to Primary Care.

More detail and resources are provided on the PAD page (accessed by clicking the drug name).

Immediate release tablets may be crushed for administration (licensed use)

 
Links :
SPC
Status :
Blue
Formulations :
  • Oral solution
Restrictions / Comments:

Important

Initiation and stabilisation for at least 1 month by the mental health specialist team before any request to transfer prescribing to Primary Care.

More detail and resources are provided on the PAD page (accessed by clicking the drug name).

1mg/ml oral solution sugar free - sestricted to prescribing for people with significant swallowing difficulties or a feeding tube in situ

 
Links :
SPC